01 April 2023: Articles
A Rare Nasopharyngeal Adenoid Cystic Carcinoma: Case Report and Literature Review
Unusual clinical course, Challenging differential diagnosis, Unusual or unexpected effect of treatment, Rare disease
Nawaf M. Alsubaie A , Ahmed Alhussien A* , Abdulrahman Alghulikah A , Saleh Alabood A , Mohammed Alsukayt A , Ibrahim Alarifi ADOI: 10.12659/AJCR.938858
Am J Case Rep 2023; 24:e938858
Table 1. Previous cases of adenoid cystic carcinoma mentioned in the literature.
| Author | Sex, age | Type of ACC | Stage* (stage group) | Surgery | Radiation | Chemotherapy | Survival and Recurrence |
|---|---|---|---|---|---|---|---|
| Saadi et al, 2003 []31 | F, 50 | NR | NR | No | Yes | Yes | Died within 6 months |
| Papadas et al, 2007 []1 | F, 57 | C | I (T1N0M0) | No | Yes | Yes | Full remission (period NR) |
| Soprani et al, 2007 []7 | M, 66 | C and S | III (T3N0M0) | No | Yes | No | Reduction of mass size after 18 months |
| Abdul-Hussein et al, 2007 []32 | F, 49 | C | IVa (T4N0M0) | Yes | Yes | No | NR |
| Khademi et al, 2011 []29 | M, 75 | NR | IVa (T4N0M0) | No | Yes | No | Local recurrence |
| M, 45 | NR | IVa (T4N0M0) | No | Yes | Yes | Full remission (period NR) | |
| M, 52 | NR | III (T3N0M0) | No | Yes | Yes | Local recurrence | |
| F, 45 | NR | IVa (T4N0M0) | No | Yes | Yes | Local recurrence | |
| M, 44 | NR | IVa (T4N0M0) | No | Yes | Yes | Local recurrence and distant metastasis | |
| Kuno and Fujii, 2013 []33 | M, 54 | C and S | IVa (T4N0M0) | No | Yes | Yes | NR |
| Liang et al, 2014 []34 | F, 31 | C and T | IVa (T4N0M0) | Yes | Yes | No | Full remission for 10 months |
| Boon et al, 2016 []35 | M, 45 | C and T | IVa (T4N2cM0) | No | Yes | Yes | Full remission for 10 months |
| Afani et al, 2016 []36 | M, 45 | C | IVa (T4N0M0) | No | Yes | Yes | Lung metastasis after 1 year; local recurrence after 3 years; complete remission of the local pathology 7 years after diagnosis |
| Phan et al, 2017 []37 | F, 71 | NR | IVa (T4N0M0) | No | Yes | Yes | Recurrence after 2 years |
| Ng and Tang, 2019 []17 | M, 21 | NR | I (T1N0M0) | Yes | Yes | No | Full remission (period NR) |
| M, 30 | NR | I (T1N0M0) | Yes | Yes | No | Full remission (period NR) | |
| Tatari et al, 2018 []38 | F, 55 | NR | NR | Yes | Yes | No | Full remission after 12 months |
| Hajar, 2020 []39 | F, 20 | C and T | IVa (T4N0M0) | No | Yes | Yes | NR |
| Sninate et al, 2021 []40 | NR, 23 | C and T | IVa (T4N0M0) | NR | Yes | Yes | NR |
| Arora et al, 2021 []41 | F, 28 | C and T | NR | Yes | Yes | No | Full remission after 4 years |
| F, 67 | C | NR | Yes | Yes | No | Full remission after 15 months | |
| F, 60 | C | NR | Yes | Yes | No | Full remission after 8 months | |
| ACC – adenoid cystic carcinoma; F – female; M – male; NR – not reported; C – cribriform; T – tubular; S – solid. * According to the American Joint Committee on Cancer (AJCC) 8 edition []. | |||||||